Search

everythinglearnresearchcommunity

for

Search:↓

Anorexia Nervosa and Bulimia Nervosa are complex eating disorders with increasing incidence among young females, significant morbidity, and varying mortality rates, requiring more research for better treatment.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

New tools show that in fish, NPY increases feeding and somatostatin decreases it.

Women with PCOS may have a higher risk of Alzheimer's disease.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Analyzing follicular fluid can help predict and improve outcomes for women with PCOS undergoing fertility treatments.

Androgens play a key role in causing PCOS (Polycystic Ovary Syndrome).

SSRIs may help manage sexual behavior in dementia patients, but they can cause long-lasting sexual dysfunction.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

Elagolix did not effectively treat polycystic ovary syndrome.

GnRH treatment can reduce breast cancer cell invasion.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

Low-dose Buserelin effectively reduces hirsutism with minimal side effects.

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

Metformin can start ovulation and may lower 17P response in PCOS, but six months is too short to improve hair growth or change body fat distribution.

A multidisciplinary approach is crucial for safe and effective hormone treatment in gender-dysphoric individuals, with specific guidelines for adolescents and adults.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Transgender treatment includes hormones and surgery, but long-term effects are unknown and counseling is needed.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

The testes control steroid production through complex interactions involving various cells and signaling molecules.

Nafarelin may effectively treat excessive hair growth in women by reducing certain hormone levels.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Leuprolide effectively reduces hair growth in hirsute women at higher doses.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.